Skip to the main content.
Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Turn Our Insights Into Your Impact

From early feasibility to commercialization, progress depends on the right decisions at the right time. Get confident in your next step with blogs, case studies, and expert insights that cut through complexity and move development forward.

 

Kate San Souci

As Director of Research Pathology at Veranex, Kate provides global oversight of the organization’s full‑service histopathology offerings and compliance programs. She began her career in 2006 with hands‑on training at a Boston‑area contract research organization, sparking a lasting passion for the art and science of histology. ASCP certified since 2010, Kate brings over 14 years of experience across diverse settings, including CROs, hospitals, veterinary diagnostics, and contract necropsy services. Her expertise spans paraffin, frozen, and plastic histology, immunohistochemistry, and post‑mortem examinations across multiple species, with particular specialization in the prosection of medical devices and implants. Alongside her technical proficiency, Kate has developed strong leadership and program management capabilities, and she is energized by a role that blends strategic oversight with hands‑on scientific practice.